发明名称 |
BISPECIFIC TRIGGER MOLECULE RECOGNIZING LYMPHOCYTE ANTIGEN CD2 AND TUMOR ANTIGEN |
摘要 |
PROBLEM TO BE SOLVED: To provide a new highly effective bispecific antibody fragment recognizing either of lymphocyte antigen CD2 and various tumor antigens. SOLUTION: This new highly effective bispecific antibody fragment comprises the first binding site for binding to the epitope of tumor antigen and the second binding site for binding to the epitope of CD2 antigen, and is represented by BAb<X, AICD2. M1>Y, or BAb<X, AICD2. M2>Y (BAb is a bispecific antibody; X is an antibody-determining group recognizing tumor antigen; AICD2. M1 and AICD2. M2 are each a monoclonal antibody recognizing CD2 antigen; Y is a part of all antibodies). COPYRIGHT: (C)2006,JPO&NCIPI
|
申请公布号 |
JP2005336207(A) |
申请公布日期 |
2005.12.08 |
申请号 |
JP20050232483 |
申请日期 |
2005.08.10 |
申请人 |
MERCK PATENT GMBH |
发明人 |
STRITTMATTER WOLFGANG;JAEGGLE CARLOTA-SILVIA;MEUER STEFAN;SHRAVEN BURKHART;WILD MARTIN |
分类号 |
G01N33/53;A61K38/00;A61K39/395;A61P35/00;C07K1/113;C07K14/485;C07K14/52;C07K14/705;C07K16/00;C07K16/18;C07K16/28;C07K16/30;C07K16/46;C07K19/00;C12N15/00;C12N15/02;C12N15/09;C12N15/13;C12N15/28;C12P21/08;C12R1/91;G01N33/531;G01N33/574;(IPC1-7):C07K16/30 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|